APLS
Apellis Pharmaceuticals, Inc. Common Stock
$40.96
0.02%
+0.01
Notify me if price changes either direction
Buy APLS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
5.2B
Enterprise value
5.2B
Trailing PE
227.5
Forward PE
-167.6561
PEG Ratio
-167.6561
Enterprise to EBITDA
91.975
Enterprise to revenue
5.221
Price to book MRQ
14.009579
Price to sales TTM
5.222719
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
1.0B
EBITDA
70.0M
Diluted EPS TTM
0.18
Total Cash (MRQ)
467.8M
Current ratio (MRQ)
3.136
Operating Cash Flow (TTM)
45.3M
APLS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
May 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
